Angiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma

Angiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma

A study of non-invasive method for liver fibrosis and prediction of hepatocellular carcinoma

significance of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and patients with hepatocellular carcinoma

Glypican-3: A novel serum and histochemical marker for hepatocellular carcinoma

3 Biochemical markers in blood can predict cirrhotic evolution of chronic hepatitis

Circulating alpha-feto protein-MRNA as amarker for hepatocellular carcinoma

Evaluation of annexin II and follistatin as potential serum markers for hepatocellular carcinoma

Glypican 3 as a novel marker for hepatocellular carcinoma

Evaluation of tumor marker (PIVAK-II) in patients with positive HCV infection with and without cirrhosis complicated and uncomplicated with hepatocellular carcinoma